Preclinical Drug Development Certificate

The graduate certificate in preclinical drug development provides advanced foundational training in preclinical aspects of drug development, translational research and regulatory control. Students must complete at least 12 units of course work including at least three courses in preclinical design and development (typically, RSCI 530 Translational Medicine: An Overview ; RSCI 531 Industrial Approaches to Drug Discovery ; RSCI 532 Early Stage Drug Development ) and one course in a related aspect of research design, regulation or ethics, subject to the approval of the program director. The program will include course work delivered in nontraditional formats such as intensive weekend  sessions and will use distance capabilities, Webcast lectures and study materials. Courses can be taken on site, by distance or as a blended combination. Students should confirm their specific course work plan in consultation with graduate advisers before beginning the program. Students who have baccalaureate degrees from accredited colleges or universities must submit an application for graduate study through the regulatory science program of the School of Pharmacy. GRE scores are not required for admission to the certificate program. Students are expected to enroll each semester until the program is completed.